Clinical Trial Update: Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 trial evaluating oral low-molecular-weight hyaluronic acid for atrophic vaginitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrophic Vaginitis

Drugs mentioned

• Oral low-molecular-weight hyaluronic acid (low-molecular-weight hyaluronic acid)

Snippet

Sponsor: AGUNCO Obstetrics and Gynecology Centre | Conditions: Atrophic Vaginitis | Phase 4 | Status: COMPLETED